Anti-Cancer Effect of IN-2001 in MDA-MB-231 Human Breast Cancer

In recent years, inhibition of HDACs has emerged as a potential strategy to reverse aberrant epigenetic changes associated with cancer, and several classes of HDAC inhibitors have been found to have potent and specific anticancer activities in preclinical studies. But their precise mechanism of acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Kyung Nan, Joung, Ki Eun, Kim, Dae-Kee, Sheen, Yhun Yhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794529/
https://www.ncbi.nlm.nih.gov/pubmed/24130929
http://dx.doi.org/10.4062/biomolther.2012.20.3.313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794529/
https://www.ncbi.nlm.nih.gov/pubmed/24130929
http://dx.doi.org/10.4062/biomolther.2012.20.3.313

Ejemplares similares